Dr. Doug Cole, M.D.


A managing partner at Flagship Pioneering, Dr. Cole previously led a multidisciplinary program at Vertex Pharmaceuticals that conducted development in tissue protection and repair, oversaw an international research collaboration and was responsible for identifying strategic market and technology opportunities. He has formerly served on the Boards of Directors of Avedro, AVEO Pharmaceuticals, CombinatoRx, Concert, CGI, Moderna, Morphotek, Receptos, Resolvyx, Selecta, Seventh Sense and Tetraphase. Dr. Cole is a member of the Board of Directors of the Spinal Muscular Atrophy Foundation. Dr. Cole holds an A.B. from Dartmouth and an M.D. from the University of Pennsylvania School of Medicine.

‹ Back